64 related articles for article (PubMed ID: 10070325)
1. Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumours.
Papamichael D; Seymour MT; Penson RT; Wilson P; Gallagher CJ; Besser GM; Slevin ML
Eur J Cancer; 1998 Dec; 34(13):2133-4. PubMed ID: 10070325
[No Abstract] [Full Text] [Related]
2. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
Vermeulen PB; Dirix LY; Pelgrims G; Van Oosterom AT
Cancer; 1995 Aug; 76(3):528-30. PubMed ID: 8625138
[No Abstract] [Full Text] [Related]
3. A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: a Penn Cancer Clinical Trials Group (PCCTG) trial.
David AK; Vaughn DJ; Holroyde CP; Armstead B; Haller DG
Am J Clin Oncol; 2000 Feb; 23(1):37-9. PubMed ID: 10683073
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin.
Gonzalez MA; Biswas S; Clifton L; Corrie PG
Br J Cancer; 2003 Aug; 89(3):455-6. PubMed ID: 12888810
[TBL] [Abstract][Full Text] [Related]
5. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-alpha 2a and radiation therapy.
Pratt CB; Rao BN; Merchant TE; Shah A; Avery L; Cain A; Bodner S; Poquette C; Tan M
Med Pediatr Oncol; 1999 Jun; 32(6):459-60. PubMed ID: 10358711
[No Abstract] [Full Text] [Related]
6. Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.
Grem JL; Jordan E; Robson ME; Binder RA; Hamilton JM; Steinberg SM; Arbuck SG; Beveridge RA; Kales AN; Miller JA
J Clin Oncol; 1993 Sep; 11(9):1737-45. PubMed ID: 8355041
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.
Temeck BK; Liebmann JE; Theodossiou C; Steinberg SM; Cook JA; Metz DC; Shawker TH; Allegra CJ; Russo A; Pass HI
Cancer; 1996 Jun; 77(12):2432-9. PubMed ID: 8640689
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
[TBL] [Abstract][Full Text] [Related]
9. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
[TBL] [Abstract][Full Text] [Related]
10. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
[TBL] [Abstract][Full Text] [Related]
11. Alpha interferon-2b, leucovorin, and 5-fluorouracil (ALF) in non-small cell lung cancer.
Quan WD; Casal R; Rosenfeld M; Walker PR
Cancer Biother Radiopharm; 1996 Aug; 11(4):229-34. PubMed ID: 10851542
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
Shapiro JD; Harold N; Takimoto C; Hamilton JM; Vaughn D; Chen A; Steinberg SM; Liewehr D; Allegra C; Monahan B; Lash A; Grollman F; Flemming D; Behan K; Johnston PG; Haller D; Quinn M; Morrison G; Grem JL
Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
Seymour MT; Slevin ML; Kerr DJ; Cunningham D; James RD; Ledermann JA; Perren TJ; McAdam WA; Harper PG; Neoptolemos JP; Nicholson M; Duffy AM; Stephens RJ; Stenning SP; Taylor I
J Clin Oncol; 1996 Aug; 14(8):2280-8. PubMed ID: 8708718
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines as immunotherapy in cancer].
Sinnige HA; Mulder NH
Ned Tijdschr Geneeskd; 1992 May; 136(21):1033-4. PubMed ID: 1603153
[No Abstract] [Full Text] [Related]
16. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
Vokes EE; Ratain MJ; Mick R; McEvilly JM; Haraf D; Kozloff M; Hamasaki V; Weichselbaum RR; Panje WR; Wenig B
J Clin Oncol; 1993 Feb; 11(2):360-8. PubMed ID: 8426214
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of unknown primary site--a complete and sustained response with interleukin-2, alpha interferon and 5-fluorouracil/leucovorin.
Dave HP; White CL; Schulof R; Avis FP
Acta Oncol; 1992; 31(5):592-3. PubMed ID: 1419108
[No Abstract] [Full Text] [Related]
19. Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Kosmidis PA; Tsavaris N; Skarlos D; Theocharis D; Samantas E; Pavlidis N; Briassoulis E; Fountzilas G
J Clin Oncol; 1996 Oct; 14(10):2682-7. PubMed ID: 8874327
[TBL] [Abstract][Full Text] [Related]
20. Palliative treatment for advanced gastrointestinal cancer: is response a suitable end-point?
Jäger E; Bernard H; Knuth A
Cancer Treat Rev; 1996 Jan; 22 Suppl A():113-5. PubMed ID: 8625335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
